Science & Enterprise subscription

Follow us on Twitter

  • Statista published a map yesterday showing the states in the U.S. with the highest rates of diabetes, this weekend'… https://t.co/NcGZkMS9xl
    about 22 hours ago
  • New post on Science and Enterprise: Infographic – Highest Diabetes Rates in U.S. https://t.co/cyC9OBviUQ #Science #Business
    about 22 hours ago
  • FDA today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor n… https://t.co/C8uIamFD3C
    about 2 days ago
  • New post on Science and Enterprise: FDA Approves Rare Infant Disease Gene Therapy https://t.co/wqx9iCTxVe #Science #Business
    about 2 days ago
  • FDA Approves First Mesothelioma Treatment in 15 Years https://t.co/PnKrL24HW0 via @medscape ATTN: @innerarchitect @deansguide
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Sanofi Aventis to Close Pennsylvania R&D Center

The Pottstown Mercury reports today that pharmaceutical company Sanofi Aventis, based in France, will close its Great Valley, Pennsylvania research and development site by July 2011. The Mercury says Sanofi Aventis will keep clinical supply and related support activities at the Great Valley site.

Elizabeth Baxter, a spokesperson for Sanofi Aventis, told the Mercury that the company plans to offer 303 Great Valley employees positions in other research facilities in Bridgewater, New Jersey and Cambridge, Massachusetts. Some 45 workers will remain to handle the clinical supply work, but 105 of the current staff will be laid off.

Related: Sanofi-aventis, Scripps to Partner on Personalized Medicines

Hat tip: Fierce Biotech

Please share Science & Enterprise ...
error

Comments are closed.